RAC 3.61% $1.47 race oncology ltd

Ann: Zantrene highly effective in Melanoma preclinical study, page-177

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,802 Posts.
    lightbulb Created with Sketch. 10675
    Yes you can be rejected because one of your earlier patents covers the same invention. If that happens it is not a bad thing.

    The basic problem when you submit a patent is you don’t know what claims will make it through the patent process. It can make sense to submit two similar patents applications and see what sticks after the process. More than once patent claim has been blocked on one patent, but granted on another patent processed by a different examiner. Such is the wonders of the patent system.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.47
Change
-0.055(3.61%)
Mkt cap ! $250.5M
Open High Low Value Volume
$1.53 $1.58 $1.46 $143.9K 96.36K

Buyers (Bids)

No. Vol. Price($)
1 230 $1.47
 

Sellers (Offers)

Price($) Vol. No.
$1.48 550 1
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.